2026-09-17 14:17:00 UTC#328141newconfirmednews
TSHA stock news
TSHA stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire9 wire items
2026-08-12 01:38:39 UTC#162325newconfirmednews
Taysha Gene Therapies targets Q4 2026 for PPQ completion, H1 2027 for REVEAL interim analysis and FDA feedback
seeking alphaimportance 0.50trust 0.70Taysha Gene Therapies, Inc. +0.30Food and Drug Administration +0.20
2026-08-11 23:15:17 UTC#161924duplicateconfirmednews
Taysha Gene Therapies (TSHA) completes pivotal trial dosing and secures $230M in financing
2026-08-11 22:12:29 UTC#161705newconfirmednews
Taysha Gene Therapies completes TSHA-102 trial dosing, secures $230M to fund operations through H2 2028
2026-08-11 21:00:47 UTC#161356duplicateconfirmednews
Taysha Gene Therapies reports Q2 2026 adjusted loss of $0.14/share on zero revenue, missing analyst estimates
2026-08-11 20:02:12 UTC#160927newconfirmednews
Taysha Gene Therapies Q2 2026 GAAP EPS of -$0.13 misses consensus estimates by $0.01
2026-08-11 20:01:00 UTC#160935newconfirmednews
Taysha Gene Therapies reports Q2 2026 net income of -$46.64 million and operating expenses of $47.35 million
2026-08-10 11:00:14 UTC#152113newforecastnews
Taysha Gene Therapies (TSHA) Q2 2026 Earnings Preview: Expected Revenue $680K, EPS Loss of $0.11
2026-07-21 12:54:00 UTC#57499newconfirmednews